Lv2
186 积分 2025-03-25 加入
Engineering IL-2 for immunotherapy of autoimmunity and cancer
27天前
已完结
Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity
4个月前
已完结
Treatment of NSCLC after chemoimmunotherapy — are we making headway?
5个月前
已完结
Development of Globo-H conjugated bacteriophage Qβ mutant virus-like particles as an anticancer vaccine
5个月前
已完结
Wnt signaling dynamics in head and neck squamous cell cancer tumor-stroma interactions
5个月前
已完结
Discovery and In Vivo Efficacy of AZ-PRMT5i-1, a Novel PRMT5 Inhibitor with High MTA Cooperativity
5个月前
已完结
One stone two birds: Introducing piperazine into a series of nucleoside derivatives as potent and selective PRMT5 inhibitors
5个月前
已完结
Discovery of TNG462: A Highly Potent and Selective MTA-Cooperative PRMT5 Inhibitor to Target Cancers with MTAP Deletion
5个月前
已完结
Artificial intelligence in drug development
7个月前
已完结
A trispecific antibody engaging T cells with tumour and myeloid cells augments antitumour immunity
7个月前
已完结
皖公网安备34019202002308
